Works by Huang, Chang-Chih


Results: 35
    1
    2
    3
    4
    5
    6
    7

    Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

    Published in:
    PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0136252
    By:
    • Chen, Yu-Mu;
    • Lai, Chien-Hao;
    • Chang, Huang-Chih;
    • Chao, Tung-Ying;
    • Tseng, Chia-Cheng;
    • Fang, Wen-Feng;
    • Wang, Chin-Chou;
    • Chung, Yu-Hsiu;
    • Wang, Yi-Hsi;
    • Su, Mao-Chang;
    • Huang, Kuo-Tung;
    • Chen, Hung-Chen;
    • Chang, Ya-Chun;
    • Lin, Meng-Chih
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, v. 13, p. 1, doi. 10.1177/17588359211018022
    By:
    • Huang, Yen-Hsiang;
    • Hung, Jen-Yu;
    • Ko, How-Wen;
    • Su, Po-Lan;
    • Lai, Chun-Liang;
    • Chang, Huang-Chih;
    • Hsia, Te-Chun;
    • Lin, Sheng-Hao;
    • Wu, Kuan-Li;
    • Yang, Cheng-Ta;
    • Su, Wu-Chou;
    • Chu, Yi-Chun;
    • Wang, Chin-Chou;
    • Liao, Wei-Yu;
    • Lin, Yen-Ting;
    • Lin, Ching-Hsiung;
    • Lin, Meng-Chih;
    • Hsu, Kuo-Hsuan;
    • Tseng, Jeng-Sen;
    • Yang, Tsung-Ying
    Publication type:
    Article
    15
    16

    A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases.

    Published in:
    PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0167923
    By:
    • Chen, Yu-Mu;
    • Fang, Ying-Tang;
    • Lai, Chien-Hao;
    • Rau, Kun-Ming;
    • Huang, Cheng-Hua;
    • Chang, Huang-Chih;
    • Chao, Tung-Ying;
    • Tseng, Chia-Cheng;
    • Fang, Wen-Feng;
    • Wang, Chin-Chou;
    • Chen, Yung-Che;
    • Chung, Yu-Hsiu;
    • Wang, Yi-Hsi;
    • Su, Mao-Chang;
    • Liu, Shih-Feng;
    • Huang, Kuo-Tung;
    • Chen, Hung-Chen;
    • Chang, Ya-Chun;
    • Chang, Yu-Ping;
    • Lin, Meng-Chih
    Publication type:
    Article
    17

    Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83185-1
    By:
    • Chen, Yung-Che;
    • Tsai, Ying-Huang;
    • Wang, Chin-Chou;
    • Liu, Shih-Feng;
    • Chen, Ting-Wen;
    • Fang, Wen-Feng;
    • Lee, Chiu-Ping;
    • Hsu, Po-Yuan;
    • Chao, Tung-Ying;
    • Wu, Chao-Chien;
    • Wei, Yu-Feng;
    • Chang, Huang-Chih;
    • Tsen, Chia-Cheng;
    • Chang, Yu-Ping;
    • Lin, Meng-Chih;
    • Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group;
    • Yu, Chong-Jen;
    • Wang, Hao-Chien;
    • Chiang, Chi-Huei;
    • Perng, Diahn-Warng
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211018022
    By:
    • Huang, Yen-Hsiang;
    • Hung, Jen-Yu;
    • Ko, How-Wen;
    • Su, Po-Lan;
    • Lai, Chun-Liang;
    • Chang, Huang-Chih;
    • Hsia, Te-Chun;
    • Lin, Sheng-Hao;
    • Wu, Kuan-Li;
    • Yang, Cheng-Ta;
    • Su, Wu-Chou;
    • Chu, Yi-Chun;
    • Wang, Chin-Chou;
    • Liao, Wei-Yu;
    • Lin, Yen-Ting;
    • Lin, Ching-Hsiung;
    • Lin, Meng-Chih;
    • Hsu, Kuo-Hsuan;
    • Tseng, Jeng-Sen;
    • Yang, Tsung-Ying
    Publication type:
    Article
    28

    Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

    Published in:
    PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0149722
    By:
    • Chen, Yu-Mu;
    • Lai, Chien-Hao;
    • Chang, Huang-Chih;
    • Chao, Tung-Ying;
    • Tseng, Chia-Cheng;
    • Fang, Wen-Feng;
    • Wang, Chin-Chou;
    • Chung, Yu-Hsiu;
    • Wang, Yi-Hsi;
    • Su, Mao-Chang;
    • Liu, Shih-Feng;
    • Huang, Kuo-Tung;
    • Chen, Hung-Chen;
    • Chang, Ya-Chun;
    • Lin, Meng-Chih
    Publication type:
    Article
    29
    30

    Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta‐analysis of real‐world survival outcomes of East Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR‐TKIs

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 32, p. 3208, doi. 10.1111/1759-7714.15111
    By:
    • Chang, Huang‐Chih;
    • Wang, Chin‐Chou;
    • Tseng, Chia‐Cheng;
    • Huang, Kuo‐Tung;
    • Chen, Yu‐Mu;
    • Chang, Yu‐Ping;
    • Lai, Chien‐Hao;
    • Fang, Wen‐Feng;
    • Lin, Meng‐Chih;
    • Chuang, Hung‐Yi
    Publication type:
    Article
    31
    32
    33
    34
    35